GeneDx Holdings Corp.WGSNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank50
3Y CAGR-6.1%
5Y CAGR-0.4%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
-6.1%/yr
Annual compound
5Y CAGR
-0.4%/yr
Recent deceleration
Percentile
P50
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$71.31M+56.0%
2024$45.72M-21.5%
2023$58.27M-32.4%
2022$86.20M-18.0%
2021$105.16M+44.7%
2020$72.70M+108.2%
2019$34.91M-